Search results

• Research chemicals
  any substance which act as a releasing agent or reuptake inhibitor of neurotransmitters such as serotonin and dopamine. DOC - There is one reported death
  19 KB (2,209 words) - 23:08, 21 April 2024
• PCP
  agonist and mild serotonin reuptake inhibitor. It has also been characterized as a potent D2 dopamine agonist but not a dopamine reuptake inhibitor in humans
  25 KB (3,130 words) - 14:33, 16 April 2024
• MDMA (section Serotonin syndrome risk)
  "Ecstasy use and serotonin syndrome: a neglected danger to adolescents and young adults prescribed selective serotonin reuptake inhibitors". International
  85 KB (10,499 words) - 14:24, 16 April 2024
• 6-APB (section Serotonin syndrome risk)
  its inhibiting effects on serotonin and norepinephrine reuptake. There is an increased risk of panic attacks and hypertensive crisis, or serotonin syndrome
  33 KB (4,870 words) - 14:34, 16 April 2024
• Antidepressants (section Selective serotonin reuptake inhibitors (SSRIs))
  dopamine reuptake inhibitors (NDRIs) Selective serotonin reuptake inhibitors (SSRIs) Serotonin and norepinephrine reuptake inhibitors (SNRIs) Serotonin antagonist
  9 KB (1,069 words) - 21:47, 13 May 2024
• Selective serotonin reuptake inhibitor
  Selective serotonin reuptake inhibitors (commonly abbreviated as SSRIs) are a class of pharmaceutical antidepressant medications. They are commonly prescribed
  15 KB (1,687 words) - 18:59, 22 November 2023
• Tramadol (section Serotonin syndrome risk)
  enantiomer is a selective agonist of the mu receptors and inhibits serotonin reuptake while the S- enantiomer inhibits noradrenaline reuptake. Tramadol acts
  22 KB (3,211 words) - 19:11, 7 April 2024
• ΑMT
  balanced reuptake inhibitor and releasing agent of the main three monoamines; serotonin, norepinephrine, and dopamine, and as a non-selective serotonin receptor
  25 KB (2,825 words) - 16:14, 28 November 2022
• 6-APDB (section Serotonin syndrome risk)
  risk of serotonin syndrome when 6-APDB is taken with many antidepressants, particularly selective serotonin reuptake inhibitors (SSRIs) and serotonin-norepinephrine
  26 KB (4,015 words) - 23:44, 21 April 2024
• Diphenhydramine
  culminating in the invention of fluoxetine (Prozac), a selective serotonin reuptake inhibitor (SSRI). Diphenhydramine, or 2-(diphenylmethoxy)-N,N-dimethylethanamine
  33 KB (4,164 words) - 20:42, 12 May 2024
• Harmala alkaloid (category Acetylcholinesterase inhibitor)
  oxidase A. Instead, it weakly inhibits reuptake of serotonin. D-THH, on the other hand, has similar potency in terms of inhibiting MAO as harmine. The effects
  13 KB (1,772 words) - 02:21, 24 September 2023
• MDAI (section Serotonin syndrome risk)
  methylenedioxy ring. MDAI has been shown to inhibit the reuptake of serotonin and has a selective affinity for the serotonin receptor. Studies have shown that the
  17 KB (2,560 words) - 07:40, 12 October 2023
• Isopropylphenidate
  still thought to act primarily as both a dopamine reuptake inhibitor and a norepinephrine reuptake inhibitor, meaning that it effectively boosts the levels
  19 KB (2,684 words) - 18:04, 30 July 2022
• Ayahuasca
  harmaline are selective and reversible inhibitors of monoamine oxidase A (MAO-A), while tetrahydroharmine is a weak serotonin reuptake inhibitor (SRI). This
  33 KB (3,884 words) - 07:33, 16 November 2023
• MDA (section Serotonin syndrome risk)
  its inhibiting effects on serotonin and norepinephrine reuptake. There is an increased risk of panic attacks and hypertensive crisis, or serotonin syndrome
  31 KB (4,379 words) - 12:23, 6 May 2024
• A-PVP (section Serotonin syndrome risk)
  its inhibiting effects on serotonin and norepinephrine reuptake. There is an increased risk of panic attacks and hypertensive crisis, or serotonin syndrome
  24 KB (3,456 words) - 00:08, 3 November 2023
• Modafinil
  Hughes, R. J. (September 2007). "Modafinil augmentation of selective serotonin reuptake inhibitor therapy in MDD partial responders with persistent fatigue
  19 KB (3,104 words) - 11:29, 16 April 2024
• Ethylphenidate
  mixture. Ethylphenidate acts as both a dopamine reuptake inhibitor and norepinephrine reuptake inhibitor, meaning it effectively boosts the levels of the
  18 KB (2,561 words) - 14:02, 16 April 2024
• Dextromethorphan
  NMDA receptor antagonist as well as much less active as a selective serotonin reuptake inhibitor. It is also about 3-fold less potent of a α3β4 nicotinic
  66 KB (8,370 words) - 12:29, 7 May 2024
• 25I-NBOMe
  δ opioid, serotonin reuptake transporter, 5-HT5A, 5-HT1B, D2, 5-HT7, D1, 5-HT3, 5-HT1E, D5, muscarinic M1-M5, H3, and the dopamine reuptake transporter
  28 KB (4,417 words) - 14:00, 16 April 2024

View (previous 20 | next 20) (20 | 50 | 100 | 250 | 500)